EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lanatoside C decelerates proliferation and induces apoptosis through inhibition of STAT3 and ROS-mediated mitochondrial membrane potential transformation in cholangiocarcinoma

Chao Zhang, Hong-Ying Yang, Long Gao, Ming-Zhen Bai, Wen-Kang Fu, Chong-Fei Huang, Ning-Ning Mi, Hai-Dong Ma, Ya-Wen Lu, Ning-Zu Jiang, Liang Tian, Teng Cai und 5 weitere

Frontiers in Pharmacology · 15.06.2023 · 14

DOI: 10.3389/fphar.2023.1098915 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 15.06.2023. Verfasst von Chao Zhang und 16 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The incidence of cholangiocarcinoma (CCA) has increased worldwide in recent years. Given the poor prognosis associated with the current management approach of CCA, new therapeutic agents are warranted to improve the prognosis of this patient population.

Methods

In this study, we extracted five cardiac glycosides (CGs) from natural plants: digoxin, lanatoside A, lanatoside C, lanatoside B, and gitoxin. Follow-up experiments were performed to assess the effect of these five extracts on cholangiocarcinoma cells and compounds with the best efficacy were selected. Lanatoside C (Lan C) was selected as the most potent natural extract for subsequent experiments. We explored the potential mechanism underlying the anticancer activity of Lan C on cholangiocarcinoma cells by flow cytometry, western blot, immunofluorescence, transcriptomics sequencing, network pharmacology and in vivo experiments.

Results

We found that Lan C time-dependently inhibited the growth and induced apoptosis of HuCCT-1 and TFK-1 cholangiocarcinoma cells. Besides Lan C increased the reactive oxygen species (ROS) content in cholangiocarcinoma cells, decreased the mitochondrial membrane potential (MMP) and resulted in apoptosis. Besides, Lan C downregulated the protein expression of STAT3, leading to decreased expression of Bcl-2 and Bcl-xl, increased expression of Bax, activation of caspase-3, and initiation of apoptosis. N-acetyl-L-cysteine (NAC) pretreatment reversed the effect of Lan C. In vivo , we found that Lan C inhibited the growth of cholangiocarcinoma xenografts without toxic effects on normal cells. Tumor immunohistochemistry showed that nude mice transplanted with human cholangiocarcinoma cells treated with Lan C exhibited decreased STAT3 expression and increased caspase-9 and caspase-3 expression in tumors, consistent with the in vitro results.

Conclusion

In summary, our results substantiates that cardiac glycosides have strong anti-CCA effects. Interestingly the biological activity of Lan C provides a new anticancer candidate for the treatment of cholangiocarcinoma.

Schlagwörter

Stichwörter der Autor:innen

Lanatoside Capoptosischolangiocarcinomamitochondrial membrane potentialreactive oxygen speciesstat3

Autor:innen und Institutionen

  • The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
  • Department of Orthopedics, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
  • State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, China.
  • Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
  • Department of Ophthalmology, The Second Hospital of Lanzhou University, Lanzhou, Gansu, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, C., Yang, H. Y., Gao, L., Bai, M. Z., Fu, W. K., Huang, C. F., Mi, N. N., Ma, H. D., Lu, Y. W., Jiang, N. Z., Tian, L., Cai, T., Lin, Y. Y., Zheng, X. X., Gao, K., Chen, J. J., & Meng, W. B. (2023). Lanatoside C decelerates proliferation and induces apoptosis through inhibition of STAT3 and ROS-mediated mitochondrial membrane potential transformation in cholangiocarcinoma. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1098915

Vancouver

Zhang C, Yang HY, Gao L, Bai MZ, Fu WK, Huang CF, et al. Lanatoside C decelerates proliferation and induces apoptosis through inhibition of STAT3 and ROS-mediated mitochondrial membrane potential transformation in cholangiocarcinoma. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1098915

BibTeX
@article{Zhang2023,
  author = {Zhang, Chao and Yang, Hong-Ying and Gao, Long and Bai, Ming-Zhen and Fu, Wen-Kang and Huang, Chong-Fei and Mi, Ning-Ning and Ma, Hai-Dong and Lu, Ya-Wen and Jiang, Ning-Zu and Tian, Liang and Cai, Teng and Lin, Yan-Yan and Zheng, Xing-Xing and Gao, Kun and Chen, Jian-Jun and Meng, Wen-Bo},
  title = {Lanatoside C decelerates proliferation and induces apoptosis through inhibition of STAT3 and ROS-mediated mitochondrial membrane potential transformation in cholangiocarcinoma},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1098915}
}
Kostenlos starten →